On Tuesday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was -2.21% drop from the session before settling in for the closing price of $3.62. A 52-week range for IRWD has been $3.26 – $15.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 5.56% over the past five years. When this article was written, the company’s average yearly earnings per share was at 101.55%. With a float of $155.77 million, this company’s outstanding shares have now reached $160.02 million.
Let’s look at the performance matrix of the company that is accounted for 267 employees. In terms of profitability, gross margin is 99.6%, operating margin of 28.68%, and the pretax margin is 18.91%.
Ironwood Pharmaceuticals Inc (IRWD) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ironwood Pharmaceuticals Inc stocks. The insider ownership of Ironwood Pharmaceuticals Inc is 2.66%, while institutional ownership is 103.20%. The most recent insider transaction that took place on Nov 18 ’24, was worth 21,869. In this transaction SVP, Chief Business Officer of this company sold 5,360 shares at a rate of $4.08, taking the stock ownership to the 284,685 shares. Before that another transaction happened on Nov 18 ’24, when Company’s SVP, COO and CFO sold 11,001 for $4.08, making the entire transaction worth $44,884. This insider now owns 309,572 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0 earnings per share (EPS) during the time that was less than consensus figure (set at 0.2) by -0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 101.55% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
You can see what Ironwood Pharmaceuticals Inc (IRWD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.50. Likewise, its price to free cash flow for the trailing twelve months is 4.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.02, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.25 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) saw its 5-day average volume 1.42 million, a negative change from its year-to-date volume of 2.86 million. As of the previous 9 days, the stock’s Stochastic %D was 42.88%. Additionally, its Average True Range was 0.29.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 7.28%, which indicates a significant decrease from 23.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.07% in the past 14 days, which was lower than the 90.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.10, while its 200-day Moving Average is $6.33. Nevertheless, the first resistance level for the watch stands at $3.63 in the near term. At $3.73, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.81. If the price goes on to break the first support level at $3.45, it is likely to go to the next support level at $3.37. The third support level lies at $3.27 if the price breaches the second support level.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
There are 160,028K outstanding shares of the company, which has a market capitalization of 566.50 million. As of now, sales total 442,740 K while income totals -1,002 M. Its latest quarter income was 91,590 K while its last quarter net income were 3,650 K.
